Felicitex Therapeutics Inc. Contracts & Agreements
21 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (3)
- Human Resources (4)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (2)
- Form of Investor Warrant (Filed With SEC on December 1, 2022)
- Form of Underwriting Agreement (Filed With SEC on October 31, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on October 31, 2022)
- Form of Investor Warrant (Filed With SEC on October 31, 2022)
- Form of Underwriting Agreement (Filed With SEC on September 16, 2022)
- Form of Representatives Warrant (Filed With SEC on September 16, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on September 16, 2022)
- Sublease between Felicitex Therapeutics Inc. and Quateris, LLC, dated March 15, 2017 (Filed With SEC on September 16, 2022)
- Material Transfer and Agreement between Felicitex Therapeutics Inc. and Barbara Ann Karmanos Cancer Institute, dated July 18, 2022 (Filed With SEC on September 16, 2022)
- Form of Stock Option Agreement for Felicitex Therapeutics Inc. 2022 Equity Incentive Plan (Filed With SEC on September 16, 2022)
- Form of Restricted Stock Award Agreement for Felicitex Therapeutics Inc. 2022 Equity Incentive Plan (Filed With SEC on September 16, 2022)
- Form of Restricted Stock Unit Award Agreement for Felicitex Therapeutics Inc. 2022 Equity Incentive Plan (Filed With SEC on September 16, 2022)
- Engagement Letter Agreement between Felicitex Therapeutics Inc. and A.T. Healey, LLC, dated April 1, 2021 (Filed With SEC on September 16, 2022)
- Employment Letter Agreement between Felicitex Therapeutics Inc. and Arthur Healey dated September 6, 2022 (Filed With SEC on September 16, 2022)
- Warrant to Purchase Common Shares between Felicitex Therapeutics Inc. and Marc Duey, dated March 17, 2020 (Filed With SEC on August 10, 2022)
- Warrant to Purchase Common Shares between Felicitex Therapeutics Inc. and Marc Duey, dated March 17, 2021 (Filed With SEC on August 10, 2022)
- Warrant to Purchase Common Shares between Felicitex Therapeutics, Inc and Marc Duey, dated November 2, 2021 (Filed With SEC on August 10, 2022)
- Agreement and Plan of Merger between Felicitex Therapeutics Inc. and TarMeta Biosciences, LLC, dated December 30, 2021 (Filed With SEC on August 10, 2022)
- License and Collaboration Agreement between Felicitex Therapeutics Inc. and Diaxonhit, dated April 16, 2014 (Filed With SEC on August 10, 2022)
- Amendment No. 1 to License and Collaboration Agreement between Felicitex Therapeutics Inc. and Diaxonhit, dated July 21, 2014 (Filed With SEC on August 10, 2022)
- Amendment No. 2 to License and Collaboration Agreement between Felicitex Therapeutics Inc. and Eurobio Scientific SA (formerly Diaxonhit), dated February 14, 2022 (Filed With SEC on August 10, 2022)
